CDRH’s Owen Faris: New Clinical Trials Program Will Speed Up IDE Approvals

In an interview with “The Gray Sheet,” CDRH’s Acting Clinical Trials Director Owen Faris discusses the device center’s new pre-market clinical trials program aimed at speeding up approval times for investigational device exemptions and increasing the number of IDE trials in the U.S.

More from Regulation

More from Policy & Regulation